Skip to main content

Advertisement

Table 6 Mechanistic outcomes. Mean (SD) unless otherwise stated

From: The effect of targeted treatment on people with patellofemoral pain: a pragmatic, randomised controlled feasibility study

Outcome Group Baseline (SD) Post Rx (SD) Mean difference (baseline-post) (SD) Confidence intervals (95%) Mean difference (MT-UC) (95% CI) ES (d) (MT - UC)
Hip abductor strength (Nm) MT 91.02 (28.45) 99.40 (27.89) 8.39 (15.28) −17.62, 0.85 −0.63 (−13.35, 12.09) −0.04
UC 81.82 (31.76) 89.57 (33.43) 7.76 (14.59) −17.56, 2.05
Knee extensor strength (Nm) MT 91.44 (28.21) 93.12 (27.19) 1.677 (14.57) −10.48, 7.12 7.96 (−2.88,18.79) 0.62
UC 94.32 (44.10) 103.95 (46.09) 9.64 (10.15) −16.46, − 2.82
Peak Hip Adduction (°) MT 5.74 (2.70) 5.92 (2.79) −0.17 (2.84) −1.89, 1.54 −0.14 (−3.12, 2.85) 0.04
UC 3.70 (3.68) 3.74 (4.99) −0.04 (4.18) −2.84, 2.77
Peak Hip Internal Rotation (°) MT −4.49 (3.26) −5.95 (5.26) 1.45 (4.98) −1.56, 4.46 1.70 (−2.56, 5.97) −0.34
UC −6.11 (4.82) −5.86 (7.22) −0.25 (5.06) −3.65, 3.15
Total coronal hip ROM (°) MT 9.77 (3.62) 9.29 (2.60) 0.47 (2.19) −0.86, 1.79 1.12 (−0.72, 3.06) −0.53
UC 10.04 (4.69) 10.74 (4.79) −0.70 (2.27) −2.23, 0.82
Total transverse hip ROM (°) MT 11.08 (2.65) 11.39 (2.08) −0.32 (2.49) −1.83, 1.19 0.46 (−1.45, 2.38) −0.20
UC 9.12 (5.76) 9.90 (5.02) −0.78 (1.93) −2.08, 0.52
  1. MT matched treatment, UC usual care group, ROM range of movement, ES effect size